Clinical Thyroidology®: Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors

Home » Clinical Thyroidology®: Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors

Levothyroxine Dosage and the Increased Risk of Second Primary Malignancy in Thyroid Cancer Survivors
Young Joo Park